TY  - JOUR
AU  - Stelzle, Dominik
AU  - Abraham, Annette
AU  - Kaminski, Miriam
AU  - Schmidt, Veronika
AU  - De Meijere, Robert
AU  - Bustos, Javier A
AU  - Garcia, Hector Hugo
AU  - Sahu, Priyadarshi Soumyaranjan
AU  - Bobić, Branko
AU  - Cretu, Carmen
AU  - Chiodini, Peter
AU  - Dermauw, Veronique
AU  - Devleesschauwer, Brecht
AU  - Dorny, Pierre
AU  - Fonseca, Ana
AU  - Gabriël, Sarah
AU  - Morales, Maria Ángeles Gómez
AU  - Laranjo-González, Minerva
AU  - Hoerauf, Achim
AU  - Hunter, Ewan
AU  - Jambou, Ronan
AU  - Jurhar-Pavlova, Maja
AU  - Reiter-Owona, Ingrid
AU  - Sotiraki, Smaragda
AU  - Trevisan, Chiara
AU  - Vilhena, Manuela
AU  - Walker, Naomi F
AU  - Zammarchi, Lorenzo
AU  - Winkler, Andrea Sylvia
PY  - 2023
UR  - http://rimi.imi.bg.ac.rs/handle/123456789/1320
AB  - Objectives: Neurocysticercosis (NCC) is a parasitic disease caused by the larval stage of the tapeworm Taenia solium. NCC mainly occurs in Africa, Latin America and South-East Asia and can cause a variety of clinical
signs/symptoms. Although it is a rare disease in Europe, it should nonetheless be considered as a differential
diagnosis. The aim of this study was to describe clinical characteristics and management of patients with NCC
diagnosed and treated in Europe.
Methods: We conducted a systematic search of published and unpublished data on patients diagnosed with NCC
in Europe (2000–2019) and extracted demographic, clinical and radiological information on each case, if available. Results: Out of 293 identified NCC cases, 59% of patients presented initially with epileptic seizures (21% focal onset); 52% presented with headache and 54% had other neurological signs/symptoms. The majority of patients had a travel or migration history (76%), mostly from/to Latin America (38%), Africa (32%) or Asia (30%). Treatment varied largely depending on cyst location and number. The outcome was favorable in 90% of the cases.
Conclusions: Management of NCC in Europe varied considerably but often had a good outcome. Travel and
migration to and from areas endemic for T. solium will likely result in continued low prevalence of NCC in Europe.Therefore, training and guidance of clinicians is recommended for optimal patient management.
PB  - Oxford University Press
T2  - Journal of Travel Medicine
T1  - Clinical characteristics and management of neurocysticercosis patients: a retrospective assessment of case reports from Europe
IS  - 1
SP  - taac102
VL  - 30
DO  - 10.1093/jtm/taac102
ER  - 

@article{
author = "Stelzle, Dominik and Abraham, Annette and Kaminski, Miriam and Schmidt, Veronika and De Meijere, Robert and Bustos, Javier A and Garcia, Hector Hugo and Sahu, Priyadarshi Soumyaranjan and Bobić, Branko and Cretu, Carmen and Chiodini, Peter and Dermauw, Veronique and Devleesschauwer, Brecht and Dorny, Pierre and Fonseca, Ana and Gabriël, Sarah and Morales, Maria Ángeles Gómez and Laranjo-González, Minerva and Hoerauf, Achim and Hunter, Ewan and Jambou, Ronan and Jurhar-Pavlova, Maja and Reiter-Owona, Ingrid and Sotiraki, Smaragda and Trevisan, Chiara and Vilhena, Manuela and Walker, Naomi F and Zammarchi, Lorenzo and Winkler, Andrea Sylvia",
year = "2023",
abstract = "Objectives: Neurocysticercosis (NCC) is a parasitic disease caused by the larval stage of the tapeworm Taenia solium. NCC mainly occurs in Africa, Latin America and South-East Asia and can cause a variety of clinical
signs/symptoms. Although it is a rare disease in Europe, it should nonetheless be considered as a differential
diagnosis. The aim of this study was to describe clinical characteristics and management of patients with NCC
diagnosed and treated in Europe.
Methods: We conducted a systematic search of published and unpublished data on patients diagnosed with NCC
in Europe (2000–2019) and extracted demographic, clinical and radiological information on each case, if available. Results: Out of 293 identified NCC cases, 59% of patients presented initially with epileptic seizures (21% focal onset); 52% presented with headache and 54% had other neurological signs/symptoms. The majority of patients had a travel or migration history (76%), mostly from/to Latin America (38%), Africa (32%) or Asia (30%). Treatment varied largely depending on cyst location and number. The outcome was favorable in 90% of the cases.
Conclusions: Management of NCC in Europe varied considerably but often had a good outcome. Travel and
migration to and from areas endemic for T. solium will likely result in continued low prevalence of NCC in Europe.Therefore, training and guidance of clinicians is recommended for optimal patient management.",
publisher = "Oxford University Press",
journal = "Journal of Travel Medicine",
title = "Clinical characteristics and management of neurocysticercosis patients: a retrospective assessment of case reports from Europe",
number = "1",
pages = "taac102",
volume = "30",
doi = "10.1093/jtm/taac102"
}

Stelzle, D., Abraham, A., Kaminski, M., Schmidt, V., De Meijere, R., Bustos, J. A., Garcia, H. H., Sahu, P. S., Bobić, B., Cretu, C., Chiodini, P., Dermauw, V., Devleesschauwer, B., Dorny, P., Fonseca, A., Gabriël, S., Morales, M. Á. G., Laranjo-González, M., Hoerauf, A., Hunter, E., Jambou, R., Jurhar-Pavlova, M., Reiter-Owona, I., Sotiraki, S., Trevisan, C., Vilhena, M., Walker, N. F., Zammarchi, L.,& Winkler, A. S.. (2023). Clinical characteristics and management of neurocysticercosis patients: a retrospective assessment of case reports from Europe. in Journal of Travel Medicine
Oxford University Press., 30(1), taac102.
https://doi.org/10.1093/jtm/taac102

Stelzle D, Abraham A, Kaminski M, Schmidt V, De Meijere R, Bustos JA, Garcia HH, Sahu PS, Bobić B, Cretu C, Chiodini P, Dermauw V, Devleesschauwer B, Dorny P, Fonseca A, Gabriël S, Morales MÁG, Laranjo-González M, Hoerauf A, Hunter E, Jambou R, Jurhar-Pavlova M, Reiter-Owona I, Sotiraki S, Trevisan C, Vilhena M, Walker NF, Zammarchi L, Winkler AS. Clinical characteristics and management of neurocysticercosis patients: a retrospective assessment of case reports from Europe. in Journal of Travel Medicine. 2023;30(1):taac102.
doi:10.1093/jtm/taac102 .

Stelzle, Dominik, Abraham, Annette, Kaminski, Miriam, Schmidt, Veronika, De Meijere, Robert, Bustos, Javier A, Garcia, Hector Hugo, Sahu, Priyadarshi Soumyaranjan, Bobić, Branko, Cretu, Carmen, Chiodini, Peter, Dermauw, Veronique, Devleesschauwer, Brecht, Dorny, Pierre, Fonseca, Ana, Gabriël, Sarah, Morales, Maria Ángeles Gómez, Laranjo-González, Minerva, Hoerauf, Achim, Hunter, Ewan, Jambou, Ronan, Jurhar-Pavlova, Maja, Reiter-Owona, Ingrid, Sotiraki, Smaragda, Trevisan, Chiara, Vilhena, Manuela, Walker, Naomi F, Zammarchi, Lorenzo, Winkler, Andrea Sylvia, "Clinical characteristics and management of neurocysticercosis patients: a retrospective assessment of case reports from Europe" in Journal of Travel Medicine, 30, no. 1 (2023):taac102,
https://doi.org/10.1093/jtm/taac102 . .